Position in CDNA
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$659
-$56 QoQ
Shares Held
38
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CDNA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026PICTON MAHONEY ASSET MANAGEMENT holds $119,494,638 across 9 Diagnostics & Research names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GH |
Guardant Health, Inc.
|
191,876 | $28,787,156 | |
| 2 | CRL |
Charles River Laboratories International, Inc.
|
116,144 | $26,340,297 | |
| 3 | NTRA |
Natera, Inc.
|
76,415 | $20,742,851 | |
| 4 | A |
Agilent Technologies, Inc.
|
107,654 | $14,299,680 | |
| 5 | RDNT |
RadNet, Inc.
|
202,005 | $12,457,648 | |
| 6 | TMO |
Thermo Fisher Scientific Inc.
|
16,776 | $8,410,815 | |
| 7 | WAT |
Waters Corp /De/
|
20,721 | $7,771,203 | |
| 8 | ILMN |
Illumina, Inc.
|
2,746 | $482,829 |
All Filings in CDNA
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $659 | 38 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $715 | 38 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1 | 38 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1 | 38 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $1 | 38 | Shares | Sole | 2025-05-07 | |
| 2024-09-30 | $1 | 38 | Shares | Sole | 2024-11-04 | |
| No filing history on record for this holder in this stock. | ||||||